FDA
.report
PMA
PMN
De Novo
MAUDE
GUDID
NDC
DailyMed
Drug Applications
FDA Letter SLAYBACK PHARMA LLC NDA 216318
Letter
NDA 216318
SLAYBACK PHARMA LLC
FDA.report
›
FDA Drug Approvals
›
SLAYBACK PHARMA LLC
›
NDA 216318
›
Letter
Application #216318
Documents
Letter
2022-06-03
Application Sponsors
NDA 216318
SLAYBACK PHARMA LLC
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.